Published research indicates that PFAS (per- and polyfluoroalkyl substances), microplastics, and agricultural chemicals such as paraquat and carbaryl are persistent environmental pollutants found in human biofluids and tissues and are predominantly stored in our fat. These compounds have been associated with endocrine disruption, immune dysregulation, metabolic interference, and systemic inflammation.

Studies also indicate that rapid fat loss, including that induced by GLP-1 therapies, can mobilize these stored lipophilic toxicants from adipose tissue into circulation, temporarily increasing measurable plasma concentrations as they relocate and redeposit in the body.

The Clari procedure uses a CE-marked plasma adsorption column designed to selectively remove PFAS, microplastics, agricultural chemicals, and plasticizers from plasma.

• General use: A single Clari procedure is typically performed with physician-guided testing to assess plasma toxicant levels and determine the need for additional sessions.
• During GLP-1-induced weight loss: Because mobilized toxins may increase transiently during active fat loss, Clari may be performed more frequently in coordination with the treating physician, with possible maintenance sessions as indicated thereafter.

Published research shows that microplastics, man-made chemicals, and other persistent environmental toxicants are detectable in human biofluids and tissues. These compounds have been associated with disruptions in mitochondrial function, metabolic regulation, cellular signaling, and oxidative stress, all of which are relevant to longevity and healthspan.

The Clari procedure uses a CE-marked plasma adsorption column to selectively remove circulating microplastics, synthetic chemical pollutants, and other persistent toxic compounds that are challenging for the body to eliminate through natural detoxification processes.

A single Clari procedure is typically performed. Ongoing coordination with your treating physician is used to monitor plasma toxicant levels and assess whether additional procedures may be clinically appropriate based on your individual response.

Published research shows that conditions such as long COVID, chronic fatigue syndrome, and other states of prolonged malaise have been associated with persistent immune activation, metabolic disruption, mitochondrial dysfunction, and autonomic imbalance.

Studies also suggest that synthetic and environmental toxicants, including microplastics, chemical pollutants, and metabolic byproducts, may play a role in exacerbating these responses by contributing to oxidative stress and impaired cellular signalling.

The Clari procedure uses a CE-marked plasma adsorption column designed to selectively remove circulating microplastics, man-made pollutants, metabolic waste products, and other persistent compounds that the body may struggle to eliminate naturally.

A single Clari procedure is typically performed. Ongoing coordination with your treating physician is used to monitor plasma toxicant levels and assess whether additional procedures may be clinically appropriate based on your individual response.

Published studies demonstrate that microplastics, man-made chemicals, and other persistent environmental toxicants are widely present in human plasma and tissues. These compounds have been associated with impaired mitochondrial function, neuroinflammation, persistent immune activation, altered metabolic signalling, and disruptions in cellular renewal and oxidative balance, all processes essential to maintaining optimal neurofunctionality, overall health, and vitality.

The Clari procedure employs a CE-marked plasma adsorption column designed to selectively remove circulating microplastics, synthetic chemical pollutants, and other persistent contaminants that are difficult for the body to eliminate naturally.

Clari may be performed more frequently, in close coordination with the treating physician, with maintenance sessions thereafter as indicated.

Published studies suggest that individuals with chronic infections, including bacterial and viral infections, long COVID, Lyme disease and Epstein-Barr virus (EBV), frequently exhibit prolonged immune activation, metabolic stress, and inflammatory byproducts in circulation.

Research also indicates that persistent environmental toxicants (such as microplastics, man-made chemicals, and metabolic waste) may contribute to further immune activation, interacting with infection-related immune pathways and cellular signaling.

The Clari procedure uses a CE-marked plasma adsorption column designed to selectively remove circulating microplastics, synthetic chemicals, metabolic waste, and other persistent compounds that may contribute to systemic toxic burden.

A single Clari procedure is typically performed, followed by collaboration with your physician to determine the need for additional sessions based on clinical evaluation.

Peer-reviewed studies show that autoimmune and immune-mediated inflammatory disorders including multiple sclerosis (MS), lupus, and rheumatoid arthritis (RA) are characterized by chronic immune activation, systemic inflammation, and impaired immune regulation.

Research has also identified associations between environmental and synthetic chemical exposures (such as microplastics, persistent pollutants, and metabolic byproducts) and immune dysregulation in susceptible individuals.

The Clari procedure uses a CE-marked plasma adsorption column designed to selectively remove circulating microplastics, man-made chemicals, metabolic byproducts, and other persistent plasma-borne compounds that have been associated with overall toxicant burden.

Clari does not remove antibodies or immune cells, and it does not diagnose, treat, or cure autoimmune disease. It is designed to reduce the measurable presence of circulating synthetic and environmental compounds.

A single Clari procedure is typically performed, followed by consultation with your treating physician to monitor plasma toxicant levels and overall health status.

Additional sessions may be considered periodically or during periods of increased inflammatory activity, as guided by clinical evaluation.

Published research has shown that environmental pollutants and man-made chemicals including PFAS, phthalates, bisphenols, and certain pesticides are frequently detected in human plasma and reproductive tissues. These compounds have been associated with endocrine disruption, reduced sperm quality, altered hormone signalling, and impaired oocyte development.

While these findings suggest potential biological effects, they are correlational and do not establish direct causation or therapeutic benefit from toxicant removal.

The Clari procedure uses a CE-marked plasma adsorption column designed to selectively remove circulating PFAS, microplastics, plasticizers, and agricultural chemicals that are challenging for the body to eliminate through natural detoxification pathways.

Clari does not diagnose or treat infertility; it is intended to reduce measurable levels of these environmental pollutants and man-made chemicals in plasma, helping to support a cleaner internal environment.

For individuals or couples planning conception, one to two Clari procedures may be performed in the weeks leading up to fertility treatments, with additional sessions considered in coordination with the treating physician.